Breaking News

Adragos Completes Acquisition of Sanofi’s Sterile Fill-Finish Site in France

Expands Adragos’ sterile injectables network, adding high-volume pre-filled syringe manufacturing capabilities to its vial and ampoule filling operations.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Maisons-Alfort facility

Adragos Pharma, a global CDMO, has completed the acquisition of a commercial-scale sterile fill-finish facility in Maisons-Alfort, France, from Sanofi. The Maisons-Alfort site is one of Europe’s largest manufacturing facilities for sterile injectables, with industrial-scale capacity for pre-filled syringes (PFS), as well as liquids and lyophilized vials. The facility is regularly audited by international health authorities, including ANSM (France), NMPA (China), MFDS (South Korea), an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters